Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Saved in:
| Title: | Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. |
|---|---|
| Authors: | Reustle A; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Di Marco M; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Meyerhoff C; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Nelde A; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany., Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Winter S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Kandabarau S; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Büttner F; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Haag M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Backert L; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Kowalewski DJ; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany., Rausch S; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Hennenlotter J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stühler V; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Scharpf M; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Fend F; Institute of Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany., Stenzl A; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Rammensee HG; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Bedke J; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Stevanović S; Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Schwab M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. matthias.schwab@ikp-stuttgart.de.; University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; German Cancer Consortium (DKTK), Partner Site Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany. matthias.schwab@ikp-stuttgart.de., Schaeffeler E; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; iFIT Cluster of Excellence (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany. |
| Source: | Genome medicine [Genome Med] 2020 Mar 30; Vol. 12 (1), pp. 32. Date of Electronic Publication: 2020 Mar 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-994X |
|---|---|
| DOI: | 10.1186/s13073-020-00731-8 |
